focus -WSS

focus

author：explore 2025-09-30 00:10:18 - browse：2757

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Test for long Covid? Researchers find new clue in blood samples

leisure time

WSS

A double vaccine crisis is endangering millions of children

Court strikes down limits on filming of police in Arizona

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Research misconduct: Proposed new rules face resistance

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

NIH director takes cautious approach to Biden drug pricing priority

focus

focus

hotspot

Bright Health sells Medicare Advantage business to Molina

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

After affirmative action ruling, medical educators look to 'holistic review'

Death toll from an explosion and collapse of a Paris building in June climbs to 3

BioMarin wins approval for gene therapy to treat hemophilia A

Providers still hesitate to prescribe buprenorphine, study finds

The cancer drug shortage isn’t new — and neither are the solutions

AI generated plenty of interest at JPM but not a lot of trust

Guidelines to prevent youth baseball injuries need more muscle

Artificial intelligence advances fuel industry trying to preserve loved ones after death

leisure time

EU regulator recommends expanding Mounjaro approval to obesity

Our daughter's deadly disease: trisomy 18. We wanted to protect her

What to know about Saharan dust affecting the US and how it can affect health

White House launches permanent pandemic office

Artificial intelligence advances fuel industry trying to preserve loved ones after death

My yearlong odyssey to get my son’s ADHD medication covered

focus

leisure time

explore

hotspot